Tag Archives: False Claims Act

Glaxo settles marketing fraud charges for record $3 billion

GlaxoSmithKline has agreed to plead guilty and pay $3 billion to resolve charges that the pharmaceutical giant fraudulently marketed the prescription drugs Paxil, Wellbutrin and Avandia, the U.S. Justice Department has announced.

Read More »


A federal agency’s response to a Freedom of Information Act request is a “report” within the meaning of the False Claims Act’s public disclosure bar. See “FOIA disclosures bar False Claims Act suit” U.S. Supreme Court. Schindler Elevator v. U.S. ...

Read More »